Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Odnoklassniki launched a deiting service for the audience of 40+

1/22/25 VKCO

NKNH received the first tons of ethylene at the new EP-600 unit

1/21/25 NKNC

Solar Group acquires 49% of Gefest Technologies, a developer of SIEM platforms

1/21/25 RTKM

Pre-IPO Exalter applications will be accepted until February 19

1/21/25 OTCI

Fesco to double agricultural exports in 2024

1/21/25 FESH

Fix Price introduces audio analytics of communication quality at checkouts

1/21/25 FIXP

Exalter has announced a Pre-IPO on MOEX Startup

1/21/25 MOEX

Exalter has announced a Pre-IPO on MOEX Startup

1/21/25 OTCI

Zymer's issuance volume in 2024 was a record ₽56 billion

1/21/25 ZAYM

RuStore became second in popularity to Google Play

1/21/25 VKCO